AYALA PHARMACEUTICALS IN (ADXS)
Institutional ownership reported to the SEC as of Q3 2024, across 17 quarters.
1
Reporting holders
$1
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Vermillion & White Wealth Management Group, LLC | $1 | 3 | 0.00% | 3q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2024 | 1 | $1 | 3 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 1 | $1 | 3 | 0 | 0 | 0 | 0.0% |
| Q1 2024 | 1 | $2 | 3 | 1 | 0 | 0 | 0.0% |
| Q2 2022 | 1 | $46.0K | 14,102 | 1 | 0 | 0 | 0.0% |
| Q1 2022 | 3 | $16.0K | 137,090 | 2 | 0 | 0 | 0.0% |
| Q4 2021 | 5 | $13.0K | 84,652 | 0 | 2 | 1 | 0.0% |
| Q3 2021 | 30 | $5.3M | 10,240,406 | 7 | 6 | 6 | 0.0% |
| Q2 2021 | 29 | $4.6M | 10,026,768 | 9 | 6 | 8 | 0.0% |
| Q1 2021 | 31 | $7.4M | 10,094,736 | 12 | 8 | 7 | 0.0% |
| Q4 2020 | 25 | $3.8M | 11,012,118 | 9 | 7 | 2 | 0.0% |
| Q3 2020 | 20 | $2.8M | 6,910,905 | 4 | 4 | 4 | 0.0% |
| Q2 2020 | 23 | $3.8M | 7,151,612 | 5 | 7 | 7 | 0.0% |
| Q1 2020 | 21 | $3.7M | 6,932,628 | 7 | 8 | 2 | 0.0% |
| Q4 2019 | 20 | $5.9M | 6,828,039 | 6 | 6 | 3 | 0.0% |
| Q3 2019 | 22 | $1.4M | 5,256,121 | 11 | 4 | 3 | 0.0% |
| Q2 2019 | 18 | $2.6M | 1,259,092 | 7 | 6 | 2 | 0.0% |
| Q1 2019 | 24 | $7.4M | 1,254,141 | 25 | 0 | 0 | 0.2% |